HealthcareServices

Genomic Selection Platform Market to Grow at a CAGR of 16.9% from 2025 to 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Genomic Selection Platform Market Size During 2025–2029?

The genomic selection platform market size has seen rapid growth in recent years. It is expected to expand from $1.94 billion in 2024 to $2.27 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.3%. The market’s historic growth can be ascribed to several factors, including the advancement of agricultural biotechnology, the increasing prominence of quantitative genetics in breeding programs, a greater focus on disease resistance in crops and livestock, the expansion of collaborative research initiatives, and escalating disease pressures along with climate variability.

The genomic selection platform market is projected for rapid growth in the coming years. It is expected to expand to $4.25 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 16.9%. This projected growth can be attributed to escalating global food demand, the advancement of precision agriculture, an increasing focus on sustainable breeding practices, the broadening scope of livestock genomics, and the rise of contract breeding and genomic services. Significant trends anticipated during this period include further developments in next-generation sequencing (NGS), the integration with digital agriculture tools, the incorporation of AI and machine learning, the adoption of cloud-based genomic data platforms, and the merging of multi-omics data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Which Factors And Drivers Are Influencing The Genomic Selection Platform Market In 2025?

The expanding integration of personalized medicine is anticipated to drive the future expansion of the genomic selection platform market. This medical methodology involves customizing treatment and prevention approaches based on an individual’s distinct genetic profile, lifestyle, and environmental factors. The growing embrace of personalized medicine is largely fueled by breakthroughs in genomics, which facilitate the accurate identification of genetic variations and the development of customized therapies. Genomic selection platforms play a crucial role in personalized medicine by offering precise genomic data, thereby enabling the customization of treatments for individual patients. These platforms streamline therapy selection by forecasting responses to interventions, thus enhancing treatment efficacy and patient outcomes and minimizing trial-and-error. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, revealed that the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023, marking a considerable rise from the 12 approvals in 2022. Consequently, the rising uptake of personalized medicine is a key driver for the growth of the genomic selection platform market. The increasing output from crops is projected to propel the expansion of the genomic selection platform market in the future. Crop yield signifies the volume of agricultural produce, such as grains, fruits, or vegetables, harvested from a specific land area. This increase in crop yield is largely attributable to progress in agricultural biotechnology, which improves plant genetics and robustness. Genomic selection platforms contribute to higher crop yields by allowing the precise identification and selection of superior-performing plant varieties, making them perfectly suited for contemporary agriculture and breeding initiatives. These platforms cut down on the time and expense associated with conventional breeding methods by delivering accurate genetic forecasts, thereby boosting farm productivity and ensuring food security. For example, in February 2024, as reported by the Department for Environment, Food and Rural Affairs, a UK-based government agency, the UK’s total cereal production, encompassing wheat, barley, oats, and other lesser cereals (like rye, triticale, and mixed grain), amounted to 24.3 million tonnes in 2022, representing an 8% increase compared to 2021. Consequently, the rising crop yields are a significant factor driving the growth of the genomic selection platform market.

What Are The Segment Types Shaping The Genomic Selection Platform Market?

The genomic selection platform market covered in this report is segmented as

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting & Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

What Are The Major Trends Driving The Growth Of The Genomic Selection Platform Market?

Major companies operating in the genomic selection platform market are focusing on developing innovative solutions, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding programs. Targeted sequencing platforms refer to genomic technologies and systems designed to sequence specific regions of the genome rather than the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, a breakthrough targeted sequencing platform that streamlines exome capture by integrating traditionally complex steps directly into its AVITI System. The platform eliminates the need for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it ideal for time-sensitive studies. Trinity expands to support custom panels across diverse applications such as oncology, respiratory diseases, and minimal residual disease (MRD). It delivers faster, more cost-effective, and more accessible sequencing, marking the first major advancement in exome capture.

Who Are The Core Companies Influencing The Genomic Selection Platform Market Landscape?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Geographies Are Emerging As Strong Markets For The Genomic Selection Platform Industry?

North America was the largest region in the genomic selection platform market in 2024. The regions covered in genomic selection platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28237&type=smp

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2025, By The Business Research Company

Genomics Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795